Genetic Technologies
GENE
#10486
Rank
NZ$6.41 M
Marketcap
NZ$1.32
Share price
0.00%
Change (1 day)
-68.08%
Change (1 year)

Revenue for Genetic Technologies (GENE)

Revenue in 2008 (TTM): NZ$21.98 Million

According to Genetic Technologies's latest financial reports the company's current revenue (TTM ) is NZ$29.6 Million. In 2007 the company made a revenue of NZ$21.71 Million an increase over the revenue in the year 2006 that were of NZ$9.94 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genetic Technologies from 2005 to 2008

Annual revenue

Year Revenue Change
2008 (TTM) NZ$21.98 M1.23%
2007 NZ$21.71 M118.23%
2006 NZ$9.94 M-2.56%
2005 NZ$10.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
NZ$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ$1.42 B 4,725.51%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$23.82 B 80,385.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.78 B 63,339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$11.94 M-59.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
NZ$42.00 B 141,794.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$75.70 B 255,617.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
NZ$1.53 B 5,085.60%๐Ÿ‡บ๐Ÿ‡ธ USA